Wu S, Yang Y, Sadegh-Nasseri S, Ashwell J D
Laboratory of Immune Cell Biology, National Cancer Institute, Bethesda, MD 20892.
J Immunol. 1993 Mar 15;150(6):2211-21.
Ligand-induced activation of T cells involves recognition of monovalent peptide Ag complexed with a cell surface MHC-encoded molecule. In contrast, antibody-induced activation of T cells typically requires external cross-linking of the TCR. To examine the mechanisms that underlie the ability of these different stimuli to signal, we have created bispecific chimeric antibody molecules (BA) that mimic Ag in several important aspects. Anti-TCR-alpha, -beta, or anti-CD3-epsilon Fab fragments were covalently coupled to an anti-MHC class II Fab fragment. These BA elicited IL-2 production or proliferation from Ag-specific T cell hybridoma cells or splenic T cells, respectively, in the presence, but not the absence, of accessory cells expressing the appropriate MHC class II molecule. This response was prevented by soluble blocking antibodies against the TCR or MHC class II. When "presented" by MHC class II-bearing accessory cells, anti-TCR x anti-MHC class II BA, like cell surface Ag, elicited IL-2 production from T cell transfectants expressing full length TCR zeta-chain but not from otherwise identical cells expressing truncated zeta; when immobilized on a plastic surface these BA were potent stimulators that induced equal amounts of IL-2 from the same cells. Purified Ag/MHC complexes immobilized on plastic were able to induce IL-2 production from T cells expressing the full length, but not the truncated, form of zeta. We hypothesize that TCR-mediated T cell activation requires stable aggregation of the TCR. In this model, activation by mobile cell surface Ag/MHC or BA occurs in two steps, occupancy-induced TCR clustering followed by stable aggregation facilitated by the presence of a full length zeta-chain. Immobilized high affinity anti-TCR antibodies, but not low affinity Ag/MHC complexes, directly promote stable receptor aggregates, and thus would not require a full length zeta-chain.
配体诱导的T细胞活化涉及识别与细胞表面MHC编码分子复合的单价肽抗原。相比之下,抗体诱导的T细胞活化通常需要TCR的外部交联。为了研究这些不同刺激信号传导能力背后的机制,我们创建了在几个重要方面模拟抗原的双特异性嵌合抗体分子(BA)。抗TCR-α、-β或抗CD3-ε Fab片段与抗MHC II类Fab片段共价偶联。在存在表达适当MHC II类分子的辅助细胞的情况下,这些BA分别从抗原特异性T细胞杂交瘤细胞或脾T细胞中诱导IL-2产生或增殖,但在不存在辅助细胞时则不会。这种反应可被针对TCR或MHC II类的可溶性阻断抗体阻断。当由携带MHC II类的辅助细胞“呈递”时,抗TCR×抗MHC II类BA与细胞表面抗原一样,从表达全长TCR ζ链的T细胞转染子中诱导IL-2产生,但从表达截短ζ链的其他相同细胞中则不能;当固定在塑料表面时,这些BA是有效的刺激剂,能从相同细胞中诱导等量的IL-2。固定在塑料上的纯化抗原/MHC复合物能够从表达全长而非截短形式ζ链的T细胞中诱导IL-2产生。我们假设TCR介导的T细胞活化需要TCR的稳定聚集。在这个模型中,由移动的细胞表面抗原/MHC或BA引发的活化分两步进行,占据诱导的TCR聚集,随后在全长ζ链存在的情况下促进稳定聚集。固定化的高亲和力抗TCR抗体而非低亲和力抗原/MHC复合物直接促进稳定的受体聚集,因此不需要全长ζ链。